NO984491L - SCF-analogpreparater og fremgangsmÕte for fremstilling av disse - Google Patents

SCF-analogpreparater og fremgangsmÕte for fremstilling av disse

Info

Publication number
NO984491L
NO984491L NO984491A NO984491A NO984491L NO 984491 L NO984491 L NO 984491L NO 984491 A NO984491 A NO 984491A NO 984491 A NO984491 A NO 984491A NO 984491 L NO984491 L NO 984491L
Authority
NO
Norway
Prior art keywords
methods
preparation
analog preparations
scf analog
stem cell
Prior art date
Application number
NO984491A
Other languages
English (en)
Norwegian (no)
Other versions
NO984491D0 (no
Inventor
Hsieng Sen Lu
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of NO984491D0 publication Critical patent/NO984491D0/no
Publication of NO984491L publication Critical patent/NO984491L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO984491A 1996-04-05 1998-09-25 SCF-analogpreparater og fremgangsmÕte for fremstilling av disse NO984491L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/628,428 US5885962A (en) 1996-04-05 1996-04-05 Stem cell factor analog compositions and method
PCT/US1997/005541 WO1997038101A1 (en) 1996-04-05 1997-04-03 Scf analog compositions and methods

Publications (2)

Publication Number Publication Date
NO984491D0 NO984491D0 (no) 1998-09-25
NO984491L true NO984491L (no) 1998-10-05

Family

ID=24518837

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984491A NO984491L (no) 1996-04-05 1998-09-25 SCF-analogpreparater og fremgangsmÕte for fremstilling av disse

Country Status (17)

Country Link
US (1) US5885962A (de)
EP (1) EP0904367B1 (de)
JP (1) JP4066388B2 (de)
KR (1) KR20000004951A (de)
CN (1) CN1214734A (de)
AT (1) ATE363488T1 (de)
AU (1) AU726663B2 (de)
BR (1) BR9708578A (de)
CA (1) CA2249181C (de)
CZ (1) CZ301598A3 (de)
DE (1) DE69737766T2 (de)
ES (1) ES2286830T3 (de)
IL (1) IL126221A0 (de)
NO (1) NO984491L (de)
SK (1) SK131098A3 (de)
WO (1) WO1997038101A1 (de)
YU (1) YU41798A (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0789761B1 (de) * 1994-11-04 2005-07-20 Applied Research Systems ARS Holding N.V. Menschliche scf, eine spleissvariante davon,ihre pharmazeutische verwendung
US5969105A (en) * 1996-10-25 1999-10-19 Feng; Yiqing Stem cell factor receptor agonists
US6967092B1 (en) 1996-10-25 2005-11-22 Mc Kearn John P Multi-functional chimeric hematopoietic receptor agonists
US6291661B1 (en) 1998-07-02 2001-09-18 Immunex Corporation flt3-L mutants and method of use
NZ516664A (en) * 1999-07-15 2003-06-30 Inst Genetics Llc Formulations and compositions for interleukin-11
EP1240196B1 (de) * 1999-12-23 2010-09-08 Universite De Geneve Auf scf peptid basiertes basolaterales sortiersignal und inhibitoren dafür
AU2002362088A1 (en) * 2001-12-06 2003-06-23 Catholic University Method and composition for inducing weight loss
CA2488497A1 (en) * 2002-06-11 2003-12-18 The Burnham Institute Neuroprotective synergy of erythropoietin and insulin-like growth factor
WO2012096960A2 (en) * 2011-01-10 2012-07-19 The Regents Of The University Of Michigan Stem cell factor inhibitor
US20150018408A1 (en) 2013-07-10 2015-01-15 The Regents Of The University Of Michigan Therapeutic antibodies and uses thereof
US20150196622A1 (en) * 2012-08-21 2015-07-16 Ali Nayer Materials and methods for modulating glucose uptake
CN105985424B (zh) * 2015-01-30 2019-08-23 苏州方舟生物医药有限公司 一种干细胞因子功能性肽段及其应用
CN105517672B (zh) * 2015-05-26 2019-06-21 中国科学院广州生物医药与健康研究院 一种人原代细胞培养基及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
RU2212411C2 (ru) * 1989-10-16 2003-09-20 Эмджен Инк. Полипептид, обладающий гемопоэтической биологической активностью фактора стволовых клеток (варианты), днк (варианты), экспрессирующий вектор (варианты), фармацевтическая композиция для гемопоэтической терапии, способ получения полипептида и способ его использования (варианты)
DK0423980T3 (da) * 1989-10-16 2000-10-09 Amgen Inc Stamcellefaktor
WO1992000376A1 (en) * 1990-06-25 1992-01-09 Immunex Corporation Mast cell growth factor
US20030125519A1 (en) * 1990-08-27 2003-07-03 Peter Besmer Ligand for the c-kit receptor and methods of use thereof
DE4224050A1 (de) * 1991-07-31 1993-02-04 Hoffmann La Roche Loesliche kit-liganden
US5525708A (en) * 1994-03-28 1996-06-11 Cytomed, Inc. Covalent dimer of kit ligand

Also Published As

Publication number Publication date
BR9708578A (pt) 1999-08-03
DE69737766D1 (de) 2007-07-12
WO1997038101A1 (en) 1997-10-16
AU726663B2 (en) 2000-11-16
CZ301598A3 (cs) 1999-01-13
AU2606497A (en) 1997-10-29
ES2286830T3 (es) 2007-12-01
CA2249181A1 (en) 1997-10-16
ATE363488T1 (de) 2007-06-15
NO984491D0 (no) 1998-09-25
EP0904367B1 (de) 2007-05-30
EP0904367A1 (de) 1999-03-31
JP2000508170A (ja) 2000-07-04
CA2249181C (en) 2009-11-17
JP4066388B2 (ja) 2008-03-26
DE69737766T2 (de) 2007-10-11
US5885962A (en) 1999-03-23
YU41798A (sh) 1999-07-28
KR20000004951A (ko) 2000-01-25
IL126221A0 (en) 1999-05-09
SK131098A3 (en) 1999-03-12
CN1214734A (zh) 1999-04-21

Similar Documents

Publication Publication Date Title
EP0653940A4 (de) Glialmitogene faktoren, ihre herstellung und verwendung.
DE68929043D1 (de) Für androgen-rezeptor-protein kodierende dna
WO2000075350A3 (en) Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
AR006188A1 (es) "composicion farmaceutica para inhibir la actividad de serinproteasa, metodo in vitro para inhibir la actividad de serinproteasa y metodo para preparar dicha composicion".
NO984491D0 (no) SCF-analogpreparater og fremgangsmÕte for fremstilling av disse
GB9902660D0 (en) Plant gene
HUP0000302A2 (hu) OB fúziós protein készítmények és módszerek
DE68927344D1 (de) Hefezellen der Gattung-Schwanniomyces
DK572487A (da) Fremgangsmaade til fremstilling af human vaekstfaktor fra endotheliale celler
EP1484339A3 (de) Kallikreinhemmende "Kunitz-Domäne"Proteine dafür kodierende Nukleinsäure
WO2002097038A3 (en) Chemokine beta-1 fusion proteins
NO20013608L (no) DNA-klon for human vevsfaktorinhibitor
GB9722320D0 (en) Human cell cycle checkpoint proteins
EE200000152A (et) Aminoterminaalselt kärbitud MCP-2 vormid, DNA molekulid, ekspressioonivektor, peremeesrakk, rekombinantne meetod proteiini valmistamiseks, proteiini kasutamine ning farmatseutiline kompositsioon
WO1997026322A3 (en) Methods and compositions for inhibiting hexokinase
IE871871L (en) Cloning and expression of acidic fibroblast growth factor
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
MY104909A (en) Peptide compounds.
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
CA2002833A1 (en) Interferon-gamma binding proteins
ES8802441A1 (es) Procedimiento para preparar laminina humana
ES8801316A1 (es) Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
DK27097A (da) Minactivin og fremgangsmåde til fremstilling deraf
NO910981L (no) Peptidforbindelser.